Roche Pharma India expands partnership with Cipla for key oncology medicines
Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India," the company said in a statement.
Bengaluru oncologist claims to be close to discovering cure for coronavirus
Bengaluru based oncologist is hopeful of finding potion that coul...
Biocon to expand generic drugs business with DKSH
As a part of the pact, DKSH will gain an exclusive license to register and commercialize th...
Covid-19 lockdown the perfect time to get rid of tobacco addiction, say oncologists; urge people to follow govt rules
The Union Health Ministry had last month asked all states to prohibit the use and spitting of smokeless tobacco.
AIIMS conducts pilot study to assess effect of radiation therapy on COVID-19 patients
Dr D N Sharma, head of the Radiation Oncology department at AIIMS and the principal investigator of the research project, said two COVID-19 patients who were on oxygen support were given the therapy last Saturday and their condition has improved since then.
CVC Capital set to buy into Cancer chain HCG, to be co-promoter
Singapore's Temasek holds a 9.4% stake in the widely held company, while Indgrowth Capital owns 1.2%. Public shareholding is 76.1%, as per latest regulatory disclosures.
Ease lockdown, let other critical patients get treatment: Hospitals
Hospitals had shut their outpatient services and deferred elective surgeries amid concerns over the spread of the coronavirus infection in healthcare facilities and among healthcare workers.
ICMR nod to pvt hospital to try plasma therapy for COVID-19 patients
This was stated by the Drugs Controller General of India in a letter to to HCG Bangalore Institute of Oncology Speciality Centre. The permission was granted on Monday under the provisions of New Drugs and Clinical Trial Rules, 2019.
Bengaluru traffic police vulnerable to lung-related diseases, says Oncologist
Chronic infections are risk factors for lung cancer, reason being exposed to environmental pollution which comprises air and water pollution, the former being more prevalent.
Test the BCG-Covid hypothesis further
Clinical trials alone can prove causation. But in a race against time, there’s an easy way to test the hypothesis involving the anti-TB vaccine further
Treatments that can wait make private hospitals wait for revenue
The impact on revenue for private hospitals is expected to last for the next two quarters, ICICI Direct said in a note. For some hospitals, the drop in patients from overseas is a concern.
With OPDs & OTs shut, cancer, HIV & other patients struggle to get treatment
With the country's entire healthcare set-up working towards fighting Covid-19, patients of diseases like HIV, cancer and renal disease who need to access hospitals regularly to continue their treatment, and are immuno-compromised, are facing quite a bit of hardship with most OPDs and operation theatres closed.
World Cancer Day: Have you been experiencing pain or swelling in bones for weeks? Time to visit the doctor
Bone cancer treatment includes combination chemotherapy and surgery.
Pharma companies set to supply ARVs for ‘treatment’
Though there is no formal cure discovered to treat the virus, the treatment protocol established in China and confirmation by physicians in Thailand show that a combination of Lopanvir and Ritonavir has worked on patients.
Smallcap Hunters: Why Medicamen looks like a big story in the making
The company has built world-class facilities in terms of processes etc. No short cuts here.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service